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Edited by Ulf-Ingo Fl€uggeAbstract Mitogen-activated protein (MAP) kinases mediate
cellular responses to a wide variety of stimuli. Activation of a
MAP kinase occurs after phosphorylation by an upstream dual-
speciﬁcity protein kinase, known as a MAP kinase kinase or
MEK. The Arabidopsis thaliana genome encodes 10 MEKs but
few of these have been shown directly to activate any of the 20
Arabidopsis MAP kinases. We show here that functional
complementation of the cell lysis phenotype of a mutant yeast
strain depends on the co-expression of the Arabidopsis MEK
AtMKK6 and the MAP kinase AtMPK13. The kinase activity
of AtMPK13 is stimulated in the presence of AtMKK6 in yeast
cells. RT-PCR analysis showed the co-expression of these two
genes in diverse plant tissues. These data show that AtMKK6
can functionally activate the MAP kinase AtMPK13.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Arabidopsis; Mitogen-activated protein kinase;
MAP kinase kinase1. Introduction
Mitogen-activated protein (MAP) kinase cascades contain a
central kinase module composed of three kinases (a MAP ki-
nase kinase kinase (MEKK), a MAP kinase kinase (MEK),
and a MAP kinase) that are sequentially activated following
the perception of various stimuli by a cell [1]. The three-com-
ponent MAP kinase module is found in all eukaryotes and any
given organism encodes a family of proteins at all three levels
of the module. One challenge in elucidating the function(s) of
these signalling pathways is to determine which of these ki-
nases interact and form part of a particular module. MEKs are
dual-speciﬁcity protein kinases that phosphorylate MAP ki-
nases on the conserved threonine and tyrosine residues of the
amino acid triplet TXY located before subdomain VIII, a
signature feature of MAP kinases. MEKs show stringent
speciﬁcity for MAP kinases, but are capable of activating more
than one MAP kinase [2]. Docking domains in MAP kinases* Corresponding author. Fax: +39-06-51494550.
E-mail address: wilson@inran.it (C. Wilson).
Abbreviations: HIS, histidine; MAP kinase, mitogen-activated protein
kinase; MBP, myelin basic protein; MEK, MAP kinase kinase; RT-
PCR, reverse transcription polymerase chain reaction; URA, uracil
0014-5793/$22.00  2004 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2004.08.051and MEKs provide some of the speciﬁcity required to ensure
that catalytic activation of the MAP kinase occurs [3].
The completed sequence of the Arabidopsis thaliana genome
shows the presence of 10 MEK genes and 20 MAP kinase
genes [4], suggesting that any given MEK can activate multiple
MAP kinases. Only a few of these kinases have been linked
together: AtMKK1 and AtMKK2 can activate AtMPK4 [5,6],
while AtMKK4 and AtMKK5 can activate AtMPK3 and
AtMPK6 [7]. Interactions between the remaining Arabidopsis
MEKs and MAP kinases have not been described so far.
Functional complementation of yeast mutant phenotypes
and two-hybrid analysis provides a readily accessible system to
isolate new genes or to study protein–protein interactions. This
approach has been used successfully in many instances, in-
cluding the interaction of MAP kinase pathway components
[8–11]. In the present report, we have used a yeast mutant
phenotype complementation assay and kinase assays to show
that the MEK AtMKK6 can functionally activate the MAP
kinase AtMPK13.2. Materials and methods
2.1. Yeast strains and plasmids
The yeast strain DL456 (Dmpk1::TRP1, leu2-3, ura3-52, trpl-1, his4,
canr) contains a disrupted MPK1 MAP kinase gene leading to a tem-
perature-sensitive cell lysis phenotype [12]. The yeast expression vector
pVT103U [13] contains a URA3 selection marker, a 2 l origin of rep-
lication, and the expression of cloned inserts is driven by the constitutive
ADH (alcohol dehydrogenase) promoter. The yeast expression vector
pUG34 [14] is a low copy centromeric plasmid and contains the me-
thionine-regulatable promoter MET25 and a HIS3 selectable marker.
The pUG34 plasmid was modiﬁed for use in the DL456 strain, ﬁrst by
deleting the GFP gene by digesting with XbaI followed by self-ligation
to produce vector pUM34 and then replacing the HIS3 gene with the
HIS4 gene. The HIS4 gene was obtained by PCR from yeast genomic
DNA using the oligonucleotides 50 AATCAAACATATGGA-
ACAGGCTCAAGCACAAAC 30 (NdeI underlined) and 50 ATTTA-
ACTGCCGGCGTTCGAAGTGATGACAATAAG 30 (NgoMIV
underlined), and included the promoter (446 bp upstream of the ATG)
and terminator (228 bp downstream of the stop codon) sequences. The
vector pUM34 was digested NdeI/NgoMIV, which removes most of the
HIS3 gene (NdeI cuts at nucleotide 191 of the HIS3 gene), and the HIS4
gene was cloned in its place to produce pUM34(H4). The functionality
of the HIS4 gene was conﬁrmed by complementation of the his4 deﬁ-
ciency of the strain DL456.
Complementation tests of yeast transformants were performed by
streaking the cells on YPD medium (2% glucose, 2% peptone, 1% yeast
extract, and 2% agar) and on YPD medium containing 1 M sorbitol,
and incubating the plates at 37 C. The pVT-AtMPK13 or pVT-ntf6blished by Elsevier B.V. All rights reserved.
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passages in liquid minimal medium (2% glucose, 0.66% yeast nitrogen
base) containing uracil (the selectable marker of the pVT103U plas-
mid), plating on the same solid medium, and then replica plating to
solid minimal medium lacking uracil. The colonies that did not grow
after replica plating were selected from the master plate to test for
pUM(H4)-AtMKK6-dependent complementation (see below) of the
mpk1 mutant. To repress the MET25 promoter in pUM34(H4)-con-
taining double transformants, cells were plated on minimal medium
(2% glucose, 0.66% yeast nitrogen base, and 2% agar) containing 1
mM methionine.
2.2. Arabidopsis cDNA isolation
The AtMPK13 cDNA was isolated from an A. thaliana cDNA li-
brary (provided by Markus Teige, Vienna Biocenter) by PCR and
cloned BamHI/XhoI into the yeast expression vector pVT103U to
produce pVT-AtMPK13. Attempts to isolate the AtMKK6 cDNA by
reverse transcription-polymerase chain reaction (RT-PCR) resulted in
two full-length but partially spliced products, one containing the ﬁrst 3
introns and the other only intron 3 (the AtMKK6 gene contains seven
introns). Splicing by overlap extension PCR [15] was used to in vitro
splice the single intron-containing cDNA to produce the full-length
intron-less cDNA. The AtMKK6 cDNA was cloned BamHI/SalI into
pUG34 and from there recloned BamHI/KpnI into pUM34(H4) to
produce pUM34(H4)-AtMKK6. The sequences and integrity of the
ATMPK13 (At5g56580) and AtMKK6 (Atlg07880) cDNAs were
conﬁrmed by sequencing. The tobacco MAP kinase ntf6 cDNA, a
putative orthologue of AtMPK13, cloned in the yeast expression
vector pVT103U (pVT-ntf6), and the yeast MPK1 gene in the vector
pFL44 have been described previously [16].
2.3. Reverse transcription-polymerase chain reaction
RT-PCR was performed on RNA isolated from A. thaliana Col-0
tissues using the Qiagen RNeasy Plant Mini Kit. The RT-PCR was
performed using the Sigma Enhanced Avian HS RT-PCR Kit ac-
cording to the manufacturer’s instructions. The oligonucleotides used
were: AtMPK13, 50 ATTTCCCCAATGGCTCTAGATCTT 30 and 50
ATTATGAAGAGAGTGAGAATTTGGGAG 30: AtMKK6, 50 TA-
GAGAATCCACCACCAACTGCTC 30 and 50 GGCTTACTTATC-
TAAGGTAGTTAACAGGTGG 30: actin 8 (Atlg49240), 50 ATGAA-
GATTAAGGTCGTGGCACCACCC 30 and 50 TTTTTATCCGAG-
TTTGAAGAGGCTACAAAC 30. The parameters for the PCRs were:
95 C 15 min, then 94 C 30 s, 57 C 40 s, 72 C 1 min, for 32 cycles,
and 72 C 10 min. Arabidopsis genomic DNA was ampliﬁed with the
same primers and parameters. All PCRs used the Hotstart Taq Poly-
merase from Qiagen.
2.4. Kinase assays
Proteins were extracted from yeast cells by centrifuging aliquots of
yeast cultures at 5000 rpm, 5 min, 4 C, resuspending the cell pellet in
an equal volume of lysis buﬀer (0.1 M Tris–HCl, pH 8.0, 20% glycerol,
1 mM DTT, 5 mM sodium ﬂuoride, 15 mM b-glycerophosphate, 1
mM PMSF, 10 lg/ml leupeptin, aprotinin, and soybean trypsin in-
hibitor, and 5 lg/ml antipain, chymoslatin, and pepstatin), adding one
volume of glass beads and vortexing for 45 min, 4 C, followed by two
centrifugations at 13 000 rpm. Immunoprecipitation of protein extracts
(100 lg yeast protein) and kinase assays was as described previously
[17]. The anti-AtMPK13 antibody was raised against the amino acid
sequence MEKREDGGILTYDG representing the ﬁrst 14 amino acids
of the AtMPK13 protein.Fig. 1. Co-expression of AtMKK6 and AtMPK13 is required for
complementation of the cell lysis defect of Dmpk1 cells. (A) Double but
not single transformants grow at 37 C in the absence of sorbitol. (B)
No complementation occurs after repression of AtMKK6 expression
by plating on medium containing 1 mM methionine. (C) No comple-
mentation occurs after plasmid losing of AtMPK13 or ntf6 (MKK6-
AtMPK13 and MKK6-Ntf6, respectively). Single or double yeast
transformants (as indicated) were plated with (+SORB) or without
()SORB) 1 M sorbitol and incubated at 37 C. The cells were plated
on minimal medium either with (MM + Met) or without (MM )Met)
1 mM methionine. MPK1 represents Dmpk1 cells transformed with the
yeast MPK1 gene as a control.3. Results
3.1. Co-expression of AtMPK13 and AtMKK6 is required for
complementation of the Dmpk1 cell lysis defect
Yeast DL456 (Dmpk1) cells are temperature-sensitive due to
the disruption of the MAP kinase gene MPK1(slt2) [12]. They
grow at 28 C but not at 37 C unless an osmotic stabiliser,
such as 1 M sorbitol, is added to the medium [12]. We used
complementation of this mutant phenotype as an assay to
determine if the MEK AtMKK6 could activate the AtMPK13
MAP kinase. DL456 cells were transformed with the plasmidspVT-AtMPK13, pVT-Ntf6, or pUM(H4)-AtMKK6 (see Sec-
tion 2), either as single transformants or as double transfor-
mants, or with the yeast MPK1 gene as a control. All
transformants could grow at 37 C in the presence of sorbitol,
but only the double transformants and the MPK1 control grew
when sorbitol was omitted from the medium (Fig. 1A). Weak
growth of cells transformed with AtMKK6 alone was observed
on occasions (Fig. 1A). However, the fact that signiﬁcant
growth similar to that observed after transformation with the
yeast MPK1 gene requires the presence of both AtMPK13 and
AtMKK6 indicates that the expression of both genes is nec-
essary for eﬃcient complementation of the lysis defect. The
complementation of the lysis defect occurred with both At-
MPK13 and its putative tobacco orthologue ntf6 in the pres-
ence of AtMKK6.
To conﬁrm that the complementation indeed required the
expression of the MEK, and as the pUG34 vector is a low copy
centromeric plasmid and thus quite stably maintained even in
the absence of selection, we used the ability to regulate the
MET25 promoter by the addition of 1 mM methionine to
the medium to repress AtMKK6 expression. Under these
conditions, the pUM(H4)-AtMKK6/pVTAtMPK13 and pUM-
(H4)-AtMKK6/pVTNtf6 double transformants could not com-
plement the lysis defect of DL456 cells (Fig. 1B), showing that
expression of AtMKK6 was necessary for the complementation.
To show that the MAP kinase (either AtMPK13 or Ntf6) was
required for the complementation, plasmid-losing experiments
were performed (see Section 2). Cells that had lost either MPK13
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the absence of sorbitol (Fig. 1C). Therefore, the co-expression of
MKK6 and MPK13 is required for complementation of the
DL456 lysis defect, suggesting that MKK6 can activate MPK13.
3.2. AtMPK13 activity is higher in the presence of AtMKK6
To further conﬁrm these data, immunokinase assays were
performed using protein extracts from yeast cells expressing
AtMKK6 alone, AtMPK13 alone, co-expressing AtMKK6
and AtMPK13, or transformed with the pVT103 empty vector.
An anti-AtMPK13 antibody, raised against a peptide corre-
sponding to the ﬁrst 14 amino acids of the AtMPK13 protein
(see Section 2), was used to immunoprecipitate the AtMPK13
protein from the protein extracts of the various transformants,
and kinase activity was measured by incubating the immuno-
precipitate in kinase buﬀer containing myelin basic protein
(MBP), a standard substrate for measuring MAP kinase ac-
tivity. Strong phosphorylation of MBP was observed after
immunoprecipitating protein extracts prepared from cells co-
expressing AtMKK6 and AtMPK13, but not from any of the
other transformants (Fig. 2). Therefore, MKK6 activates the
kinase activity of MPK13 and this activation can functionally
activate MPK13 as shown by the complementation assay de-
scribed above.
3.3. Expression analysis of AtMPK13 and AtMKK6 in
Arabidopsis tissues
The TAIR (http://www.arabidopsis.org/) and TIGR (http://
www.tigr.org/tdb/e2kl/athl/) database entries for AtMPK13
(Atlg07880) show a cDNA of 765 bp encoding a protein of 254
amino acids. However, in silico analyses of the MAP kinase
gene family have predicted an open reading frame of 1092 bp
encoding a protein of 363 amino acids [4,18], in keeping withFig. 2. AtMPK13 activity is higher in the presence of AtMKK6. Im-
munokinase assays of extracts from cells transformed with the
pVT103U empty vector (C), pUM(H4)-AtMKK6 (MKK6), pVT-At-
MPK13 (MPK13), or with both pUM(H4)-AtMKK6 and VT-
AIMPK13 (MKK6, MPK13). The phosphorylation of MBP is shown
(top panel) and Coomassie staining of the protein extracts as a loading
control (bottom panel).the gene and protein structure of the MAP kinase family, and
as annotated in the MIPS (http://mips.gsf.de/proj/thal/) and
PlantsP (http://plantsp.sdsc.edu/) databases. The AtMPK13
cDNA sequence determined in this study was in agreement
with the MIPS annotation, which, together with the expression
analysis described below, provides experimental evidence for
the correct annotation of AtMPK13 as a 363 amino acid
protein.
We examined the expression proﬁle of AtMKK6 and At-
MPK13 in various Arabidopsis tissues using RT-PCR analy-
sis. The oligonucleotides used for the analysis were located on
either side of the last intron of each gene, as were the oligo-
nucleotides for the ampliﬁcation of the actin 8 gene used as a
control (Fig. 3). Ampliﬁcation of genomic DNA was com-
pared to the cDNA ampliﬁcations to ensure that there was no
DNA contamination of the samples (Fig. 3). The RT-PCR
analyses showed co-expression of AtMKK6 and AtMPK13 in
roots, ﬂower buds, and stems (Fig. 3). Expression of AtMKK6
was also observed in cauline and rosette leaves and in siliques,
but no expression of AtMPK13 was detectable in these tissues.
Either AtMPK13 is not expressed in these tissues or it is un-
detectable due to a low level of expression or because it is only
expressed in a small number of cells. As mentioned above, a
MEK may activate multiple MAP kinases so that AtMKK6
might have other substrates in those tissues in whichFig. 3. Expression analysis of AtMPK13 and AtMKK6 in Arabidopsis
tissues using RT-PCR. Ampliﬁcation of the actin 8 gene was used as a
control, while ampliﬁcation of genomic DNA was used to demonstrate
the absence of DNA contamination in the samples. The sizes of the
amplicons are shown on the right. A 100 bp DNA ladder from
Fermentas, shown on the left, was used as a molecular size marker.
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are not quantitative, the much stronger ampliﬁcation obtained
for both AtMKK6 and AtMPK13 in roots and ﬂower buds
relative to the other tissues, and compared to the control
ampliﬁcations of actin, suggests that they are expressed at a
higher level in these two tissues.4. Discussion
There are 10 MEK genes and 20 MAP kinase genes in the
Arabidopsis genome [4], but the majority of the data pub-
lished to date concerns a relatively small number of these
kinases (see [19] for review). Interactions between the com-
ponents of a cascade are fundamental for their function, and
various interaction domains have been identiﬁed in MAP
kinases and in their activators, inactivators, and substrates
[3,20]. Even though two such kinases may physically interact,
however, it does not necessarily mean that catalytic activation
occurs. For example, NtMEK1 from tobacco can physically
interact with the MAP kinases Ntf4 and Ntf6, but function-
ally activates only Ntf6 [16]. The tobacco MAP kinase SIPK
physically interacts with the MEK SIPKK, but does not seem
to be phosphorylated by SIPKK [21]. Instead, SIPK is acti-
vated by another MEK, NtMEK2 [22]. This implies that these
proteins contain characteristics that not only determine pro-
tein–protein interaction, but also the ability to activate the
kinase. Indeed, distinct domains may operate independently
in protein binding and protein phosphorylation/activation
[20]. Therefore, it is important to show that a MEK and a
MAP kinase interact in a manner that leads to the functional
activation of the MAP kinase, as shown in this work for
AtMPK13.
It was shown recently that mutation of the AtMKK6
(ANQ1) gene causes cytokinesis defects in Arabidopsis [23].
AtMKK6 is the putative orthologue of NtMEKl from to-
bacco, which forms part of the NPK1-NtMEK1-Ntf6 MAP
kinase signalling pathway that is involved in cytokinesis
[16,23]. The putative orthologues of NPK1 in Arabidopsis are
ANP1, ANP2, and ANP3, mutation of which also results in
cytokinesis defects [24]. To date, there have been no data to
directly link the components of the proposed ANPl/2/3-At-
MKK6-AtMPK13 pathway. The requirement of AtMKK6 for
the functional complementation of the yeast mpk1 mutant by
AtMPK13 and the increase in AtMPK13 kinase activity in the
presence of AtMKK6 show that AtMKK6 functionally acti-
vates AtMPK13. These data are supported by the expression
analysis, which indicates a high level of co-expression of the
two genes in roots and ﬂower buds. In summary, the present
report provides evidence that AtMKK6 and AtMPK13 form
part of the Arabidopsis ANP1/2/3-AtMKK6-AtMPK13 MAP
kinase signalling pathway.Acknowledgements: This research was supported by the Austrian
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